NCT05328869

Brief Summary

The aim of this study was to investigate the effects of relaxation training on menstrual pain severity, menstrual symptoms, impact of quality of life, impact of work/academic performance, impact of social activity level and anxiety level in women with primary dysmenorrhea (PD) complaints.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2022

Shorter than P25 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 7, 2022

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 14, 2022

Completed
1 month until next milestone

Study Start

First participant enrolled

May 15, 2022

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 15, 2022

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2022

Completed
Last Updated

April 14, 2022

Status Verified

April 1, 2022

Enrollment Period

5 months

First QC Date

April 7, 2022

Last Update Submit

April 7, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Menstrual pain intensity

    Menstrual pain intensity will be evaluated with Visual Analogue Scale. This scale consists of a 10 cm horizontal line. The starting point "0" = "no pain", while "10" = "unbearable pain". Individuals will be asked to mark on a 10 cm straight line according to the level of pain they feel. Pain intensity will be recorded by measuring the distance between the beginning of the line and the marked place.

    change from baseline at an average of 2 weeks

Secondary Outcomes (5)

  • Menstrual symptoms

    change from baseline at an average of 2 weeks

  • Impacts of academic/work performance

    change from baseline at an average of 2 weeks

  • Impacts of life quality

    change from baseline at an average of 2 weeks

  • Impacts of social activity

    change from baseline at an average of 2 weeks

  • Anxiety level

    change from baseline at an average of 2 weeks

Study Arms (2)

Relaxation group

EXPERIMENTAL

Jacobson progressive relaxation training will be applied

Other: Relaxation training

Control group

OTHER

No intervention will be applied

Other: No intervention

Interventions

Relaxation training will be performed under the supervision of a physiotherapist. The training is carried out from the estimated day of ovulation (cycle length in days minus 14) until the next menstrual period begins

Relaxation group

No intervention will be applied. The natural process will be followed from the estimated day of ovulation (cycle length in days minus 14) until the next menstrual period begins

Control group

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsPrimary dysmenorrhea is a gynecological problem that can be seen in most women.
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Women with primary dysmenorrhea complaint according to the Primary Dysmenorrhea Consensus Guide,
  • Over 18 years of age,
  • Having a mean pain intensity of moderate and higher according to the Visual Analogue Scale in the last 6 months,
  • Having a regular menstrual cycle (28±7 days),
  • Volunteered to participate in the study.

You may not qualify if:

  • Having a pathological history and radiological findings pointing to secondary dysmenorrhea,
  • Using oral contraceptives/antidepressants at least 6 months,
  • Receiving hormone therapy,
  • Undergoing pelvic surgery,
  • Pregnant,
  • Giving birth,
  • Using an intrauterine device,
  • Having neurological, orthopedic and/or rheumatological diseases
  • Having a psychiatric disease,
  • Having a history of malignancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Relaxation Therapy

Intervention Hierarchy (Ancestors)

Mind-Body TherapiesComplementary TherapiesTherapeuticsBehavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Seyda Toprak Celenay

    Ankara Yildirim Beyazıt University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Seyda Toprak Celenay

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
associate professor

Study Record Dates

First Submitted

April 7, 2022

First Posted

April 14, 2022

Study Start

May 15, 2022

Primary Completion

October 15, 2022

Study Completion

December 15, 2022

Last Updated

April 14, 2022

Record last verified: 2022-04